Universal Vision Biotechnology Co., Ltd.TPEX: 3218

Change of the principal financial and accounting officer of the Company

· Issued by Universal Vision Biotechnology Co., Ltd.
Close
Today's Information

Provided by: UNIVERSAL VISION BIOTECHNOLOGY CO., LTD.
SEQ_NO 1 Date of announcement 2022/08/12 Time of announcement 18:02:14
Subject
 Change of the principal financial and accounting
officer of the Company
Date of events 2022/08/12 To which item it meets paragraph 8
Statement
1.Type of personnel changed (please enter:
spokesperson, acting spokesperson, important
personnel (CEO, COO, CMO, CSO, etc.), financial
 officer, accounting officer, corporate governance
officer, chief information security officer,research
 and development officer, internal audit officer, or
 designated and non-designated representatives):Principal financial and
 accounting officer
2.Date of occurrence of the change:2022/08/12
3.Name, title, and resume of the previous position holder:
Principle financial and accounting officer:Jason Wang, financial & accounting
director
4.Name, title, and resume of the new position holder:
Principle financial and accounting officer:Sophia Lien (Substitute),certified
public accountant of MaoChun CPA Firm; and vice president of YFY Biotech
Management Co.
5.Type of change (please enter: "resignation",
"position adjustment", "dismissal", "retirement",
"death" or "new replacement"):Resignation
6.Reason for the change:Career plans
7.Effective date:2022/08/12
8.Any other matters that need to be specified:
(1)Sophia Lien serves as the acting principle financial and accounting
officer.
(2) The official principle financial and accounting officer appointment will
be announced after the board's approval.

Earlier from Universal Vision Biotechnology

All Universal Vision Biotechnology news releases